Shield Therapeutics to assume full U.S. commercial control of ACCRUFeR
Shield Therapeutics says it will assume full commercial control of ACCRUFeR in the U.S.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.